Size and Shape of the Corpus Callosum in Adult Niemann-Pick Type C Reflects State and Trait Illness Variables

References

1. 1.↵
   1. Vanier M,
   2. Millat G

   . Niemann-Pick disease type C. Clin Genet 2003;64:269–81

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Scriver C,
   2. Beaudet A,
   3. Sly W,
   4. et al

   1. Patterson M,
   2. Vanier M,
   3. Suzuki K,
   4. et al

   . Niemann-Pick disease type C: a lipid trafficking disorder. In: Scriver C, Beaudet A, Sly W, et al. eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001:3611–34
3. 3.↵
   1. Sadock B,
   2. Sadock V,
   3. Ruiz P

   1. Walterfang M,
   2. Mocellin R,
   3. Velakoulis D

   . The neuropsychiatry of neuroendocrine and neurometabolic disorders. In: Sadock B, Sadock V, Ruiz P, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2009:592–618
4. 4.↵
   1. Paul C,
   2. Boegle A,
   3. Maue R

   . Before the loss: neuronal dysfunction in Niemann-Pick type C disease. Biochim Biophys Acta 2004;1685:63–76

   PubMed
5. 5.↵
   1. Vanier M

   . Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 1999;24:481–89

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Walkley S,
   2. Suzuki K

   . Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta 2004;1685:48–62

   PubMedWeb of Science
7. 7.↵
   1. Grau AJ,
   2. Brandt T,
   3. Weisbrod M,
   4. et al

   . Adult Niemann-Pick disease type C mimicking features of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:552

   FREE Full Text
8. 8.↵
   1. Josephs KA,
   2. Van Gerpen MW,
   3. Van Gerpen JA

   . Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry 2003;74:528–29

   Abstract/FREE Full Text
9. 9.↵
   1. Palmeri S,
   2. Battisti C,
   3. Federico A,
   4. et al

   . Hypoplasia of the corpus callosum in Niemann-Pick type C disease. Neuroradiology 1994;36:20–22

   CrossRefPubMed
10. 10.↵
    1. Trendelenburg G,
    2. Vanier MT,
    3. Maza S,
    4. et al

    . Niemann-Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry 2006;77:997–98

    FREE Full Text
11. 11.↵
    1. Trouard T,
    2. Heidenreich R,
    3. Seeger J,
    4. et al

    . Diffusion tensor imaging in Niemann-Pick type C disease. Pediatr Neurol 2005;33:325–30

    CrossRefPubMed
12. 12.↵
    1. Yang CC,
    2. Su YN,
    3. Chiou PC,
    4. et al

    . Six novel NPC1 mutations in Chinese patients with Niemann-Pick disease type C. J Neurol Neurosurg Psychiatry 2005;76:592–95

    Abstract/FREE Full Text
13. 13.↵
    1. Walterfang M,
    2. Fahey M,
    3. Fietz M,
    4. et al

    . The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 2006;18:158–70

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Walterfang M,
    2. Fietz M,
    3. Abel L,
    4. et al

    . Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. J Inherit Metab Dis 2009 Jul 17 [Epub ahead of print]
15. 15.↵
    1. Sevin M,
    2. Lesca G,
    3. Baumann M,
    4. et al

    . The adult form of Niemann-Pick disease type C. Brain 2007;130:120–33

    Abstract/FREE Full Text
16. 16.↵
    1. Walterfang M,
    2. Fahey M,
    3. Desmond P,
    4. et al

    . White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology 2010;75:49–56

    Abstract/FREE Full Text
17. 17.↵
    1. Lepore F,
    2. Pitto M,
    3. Jasper H

    1. Pandya D,
    2. Seltzer B

    . The topography of commisural fibers. In: Lepore F, Pitto M, Jasper H, eds. Two Hemispheres, One Brain Functions of the Human Corpus Callosum. New York: Alan R Liss; 1986:47–73
18. 18.↵
    1. Hampel H,
    2. Teipel SJ,
    3. Alexander GE,
    4. et al

    . Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998;55:193–98

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Teipel SJ,
    2. Hampel H,
    3. Alexander GE,
    4. et al

    . Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 1998;51:1381–85

    Abstract/FREE Full Text
20. 20.↵
    1. Ong W,
    2. Kumar U,
    3. Switzer R,
    4. et al

    . Neurodegeneration in Niemann-Pick type C disease mice. Exp Brain Res 2001;141:218–31

    CrossRefPubMed
21. 21.↵
    1. Ikuta F

    1. Higashi Y,
    2. Murayama S,
    3. Pentchev P,
    4. et al

    . Pathology of Niemann-Pick type C: studies of murine mutant. In: Ikuta F, ed. Neuropathology in Brain Research. Amsterdam, Netherlands: Elsevier; 1991:85–102
22. 22.↵
    1. Ahmad I,
    2. Lope-Piedrafita S,
    3. Bi X,
    4. et al

    . Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick type C mine. J Neurosci 2005;82:811–21

    CrossRef
23. 23.↵
    1. Lope-Piedrafita S,
    2. Totenhagen J,
    3. Hicks C,
    4. et al

    . MRI detects therapeutic effects in weanling Niemann-Pick type C mice. J Neurosci Res 2008;86:2802–07

    CrossRefPubMedWeb of Science
24. 24.↵
    1. German D,
    2. Liang C,
    3. Song T,
    4. et al

    . Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 2002;109:437–50

    CrossRefPubMedWeb of Science
25. 25.↵
    1. German D,
    2. Quintero E,
    3. Liang C,
    4. et al

    . Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J Comp Neurol 2001;433:415–25

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Iturriaga C,
    2. Pineda M,
    3. Fernandez-Valero E,
    4. et al

    . Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci 2006;249:1–6

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Walterfang M,
    2. Malhi GS,
    3. Wood AG,
    4. et al

    . Corpus callosum size and shape in established bipolar affective disorder. Aust N Z J Psychiatry 2009;43:838–45

    Abstract/FREE Full Text
28. 28.↵
    1. Walterfang M,
    2. Wood A,
    3. Reutens D,
    4. et al

    . Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis. Psych Res Neuroimaging 2009;173:77–82

    CrossRef
29. 29.↵
    1. Walterfang M,
    2. Wood A,
    3. Reutens D,
    4. et al

    . Morphology of the corpus callosum at different stages of schizophrenia: a cross-sectional study in first-episode and chronic illness. Br J Psychiatry 2008;192:429–34

    Abstract/FREE Full Text
30. 30.↵
    1. Walterfang M,
    2. Yung A,
    3. Wood A,
    4. et al

    . Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophr Res 2008;103:1–10

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Walterfang M,
    2. Chanen AM,
    3. Barton S,
    4. et al

    . Corpus callosum morphology and relationship to orbitofrontal and lateral ventricular volume in teenagers with first-presentation borderline personality disorder. Psychiatry Res 2010;183:30–37

    CrossRefPubMed
32. 32.↵
    1. Abel L,
    2. Walterfang M,
    3. Fietz M,
    4. et al

    . Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem and biochemical deficits. Neurology 2009;72:1083–86

    Abstract/FREE Full Text
33. 33.↵
    1. Patterson MC,
    2. Vecchio D,
    3. Prady H,
    4. et al

    . Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 2007;6:765–72

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Holmes A,
    2. Blair R,
    3. Watson J,
    4. et al

    . Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab 1996;16:7–22

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Holm S

    . A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65–70
36. 36.↵
    1. Smith SM,
    2. Zhang Y,
    3. Jenkinson M,
    4. et al

    . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Galanaud D,
    2. tourbah A,
    3. Lehericy S,
    4. et al

    . 24 month treatment with miglustat of three patients with Niemann-Pick type C: follow up using brain spectroscopy. Mol Genet Metab 2009;96:55–58

    CrossRefPubMed
38. 38.↵
    1. Tedeschi G,
    2. Bonavita S,
    3. Barton N,
    4. et al

    . Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease. J Neurol Neurosurg Psychiatry 1998;65:72–79

    Abstract/FREE Full Text
39. 39.↵
    1. Scheel M,
    2. Abegg M,
    3. Lanyon LJ,
    4. et al

    . Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick Type C patient. Mol Genet Metab 2010;99:291–95

    CrossRefPubMed
40. 40.↵
    1. Sydykova D,
    2. Stahl R,
    3. Dietrich O,
    4. et al

    . Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb Cortex 2007;17:2276–82

    Abstract/FREE Full Text
41. 41.↵
    1. Tomimoto H,
    2. Lin JX,
    3. Matsuo A,
    4. et al

    . Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia. J Neurol 2004;251:398–406

    CrossRefPubMedWeb of Science
42. 42.↵
    1. March P,
    2. Thrall M,
    3. Brown D,
    4. et al

    . GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol 1997;94:164–72

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Sarna J,
    2. Larouche M,
    3. Marzban H,
    4. et al

    . Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J Comp Neurol 2003;456:279–91

    CrossRefPubMedWeb of Science
44. 44.↵
    1. Zervas M,
    2. Dobrenis K,
    3. Walkley S

    . Neurons in Niemann-Pick type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 2001;60:49–64

    PubMedWeb of Science
45. 45.↵
    1. Goodrum J,
    2. Pentchev P

    . Cholesterol reutilization during myelination of regenerating PNS axons is impaired in Niemann-Pick disease type C mice. J Neurosci Res 1997;49:389–92

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Takikita S,
    2. Fukuda T,
    3. Mohri I,
    4. et al

    . Perturbed myelination process of premyelination oligodendrocyte in Niemann-Pick type C mouse. J Neuropathol Exp Neurol 2004;63:660–73

    PubMedWeb of Science
47. 47.↵
    1. Kloppel S,
    2. Draganski B,
    3. Golding CV,
    4. et al

    . White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008;131:196–204

    Abstract/FREE Full Text
48. 48.↵
    1. Pierrot-Deseilligny C,
    2. Rivaud S,
    3. Penet C,
    4. et al

    . Latencies of visually guided saccades in unilateral hemispheric cerebral lesions. Ann Neurol 1987;21:138–48

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Schlag J,
    2. Dassonville P,
    3. Schlag-Rey M

    . Interaction of the two frontal eye fields before saccade onset. J Neurophysiol 1998;79:64–72

    Abstract/FREE Full Text